No Picture
News

Innovent and Xuanzhu Enter into Clinical Trial Collaboration Investigating Combination Therapy of Sintilimab (PD-1 inhibitor) and A Novel ADC Candidate for Advanced Solid Tumors in China

ROCKVILLE, Md. and SUZHOU, China, Dec. 27, 2023 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic,… […]

Advertise With Biotech Networks
News

Innovent and SanegeneBio Enter Strategic Collaboration to Develop siRNA Drug for the Treatment of Hypertension

ROCKVILLE, Md. and SUZHOU, China, Dec. 26, 2023 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic,… […]

News

FDA Roundup: December 22, 2023

SILVER SPRING, Md., Dec. 22, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: The FDA does not anticipate issuing the FDA Roundup […]

Advertise With Biotech Networks
News

WAINUA™ (eplontersen) Granted First-Ever Regulatory Approval in the US for the Treatment of Adults With Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis

WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca and Ionis’ WAINUA™ (eplontersen) has been approved in the US for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults, commonly referred to as hATTR-PN or ATTRv-PN.1 WAINUA is the […]

Advertise With Biotech Networks
News

As Public Health Agencies Transform, ASTHO Launches a New Interactive Data Visualization Tool to Track Progress and Trends

ASTHO profile data indicates the public health workforce has more temporary and vacant positions than ever before ARLINGTON, Va., Dec. 21, 2023 /PRNewswire/ — The Association of State and Territorial Health Officials (ASTHO) today released […]